Bartlett & Co. LLC Horizon Therapeutics Public LTD CO Transaction History

Bartlett & Co. LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$98.98 - $115.74 $491,237 - $574,417	-4,963 Reduced 7.01%	65,882 $7.62 Million
Q2 2023 Jul 14, 2023	BUY	$96.34 - $112.38 $6.1 Million - $7.12 Million	63,345 Added 844.6%	70,845 $7.29 Million
Q4 2022 Jan 04, 2023	SELL	$62.39 - $113.8 $155,975 - $284,500	-2,500 Reduced 25.0%	7,500 $854,000
Q2 2022 Aug 02, 2022	SELL	$79.4 - $116.36 $110,048 - $161,274	-1,386 Reduced 12.17%	10,000 $798,000
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $33,358 - $42,386	386 Added 3.51%	11,386 $1.2 Million

Q3 2021 Oct 15, 2021	BUY	$91.91 - $110.37 $1.01 Million - $1.21 Million	11,000 New	11,000 $1.21 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Bartlett & Co. LLC with notifications on news.